[ALNY] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -20.65%
YoY- -34.19%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 224,818 220,553 103,962 44,714 29,907 15,932 8,709 71.87%
PBT -274,673 -188,331 -177,903 -218,521 -163,481 -118,420 -90,129 20.39%
Tax 2,729 1,228 1,326 960 79 -2,577 -2,092 -
NP -277,402 -189,559 -179,229 -219,481 -163,560 -118,420 -90,129 20.59%
Tax Rate - - - - - - - -
Total Cost 502,220 410,112 283,191 264,195 193,467 134,352 98,838 31.10%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -123.39 -85.95 -172.40 -490.86 -546.90 -743.28 -1,034.89 -29.83%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -2.29 -1.61 -1.56 -2.02 -1.63 -1.34 -1.05 13.87%
EPS Diluted -2.29 -1.61 -1.56 -2.02 -1.63 -1.34 -1.05 13.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.